Financing makes the most sense to me as “big news”.
Financing makes the most sense to me as “big news”. It’s been teased as in the works (in discussions) numerous times over the past 2-4 weeks, both government and bank/institutional. This could also come via partnerships for GVHD, MS, or NASH. It’s the kind of thing they have been working on and that we desperately need. That’s my best guess. It would come along with updates to studies, other indications, and where we stand with both Mexico and the FDA of course.
As for the other big things being thrown about...
There doesn’t seem to be enough momentum on the enrollment of trials to warrant a call based on a major update to those. Like that we’ve completed enrollment, for instance. A thing that I’ve seen hypothesized more than once on the boards.
It also doesn’t make sense that we would get any sort of approval outside of compassionate use at this point. Though we do deserve it. Even then, I have a hard time believing that the FDA would all of a sudden be in our corner fighting for us. (I would love to be wrong) All indications are that the FDA favors bigger pharma and wants to see cold hard Leronlimab facts before moving an inch. Again, I hope I’m wrong. It would be amazing if what Trump said about “big therapeutic” news coming soon was for us. I just won’t believe it until I see it based on our treatment from them to date.
Uplisting to NYSE announcement is plausible based on Nader saying that we currently satisfy the requirements and saying we were a week or two away from an announcement. I believe that it would be a submission of application announcement, not a stamp of approval from NYSE. I don’t know the rules but I’m guessing there’s at least some sort of timeframe for them to review and execute the submission. I can’t imagine it happens as soon as you submit.
There’s a chance they have their pdufa date to announce but that would be a very quick turnaround time. That being said, the FDA did review and find the missing information pretty damn fast so maybe they can approve it quickly at this point.
Lastly, I seriously doubt that NP asks for an increase in shares. I haven’t been invested here for more than a year and a half but for that stretch he has been extremely vocal about what he thinks the value of the company is worth (a ton) AND that he doesn’t want to dilute. He seems heavily focused and very dedicated to that effort. With all that we have going for us, and it’s a lot, he has referenced financing options/offers many times and I don’t see him changing now. Now more than ever he likely has the leverage he needs to find it without adding shares.
So long story short, I’m predicting it will be a major financing announcement with an outside shot that they’ve applied for an up-list or have a pdufa date. We’ll get a good tidbit or two on the other ongoing activities as well. I’m firmly in the camp that believes at least one big thing is brewing. Looking forward to it. Figures it would happen on a holiday weekend and we’d have to wait an extra day. Good luck all!
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Cigarette smoke is getting treated like a revenue problem in Tampa, and that is a far more interesting signal than another ribbon-cutting photo. Seminole Hard Rock Hotel & Casino Tampa opened The Breeze: A Smoke-Free Experience by Hard Rock on Nov. 19, 2026, following a $30 million transformation aimed at guests who want clean-air casino time from arrival through...
Continue Reading
One partnership can look like a gold mine from across the valley; getting the ore out is another matter entirely. DarioHealth has struck a strategic partnership with WebMD Health Services that could put its multi-condition care platform in front of an enormous commercial ecosystem: more than 3,500 employers and 65 million covered lives. That is a meaningful distribution...
Continue Reading
Certification Is Useful, Not a Victory Lap A battery box earning a safety certificate is not usually thrilling stuff, but the timing matters here. On Nov. 19, 2026, JDEnergy laid out its North American storage pitch at RE+ in Las Vegas while electricity demand is getting shoved higher by industrial buildout and AI data centers. Add more variable renewable generation to an...
Continue Reading
A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...
Continue Reading
Ductless mini-splits have slipped from contractor jargon into a serious conversation about how homes and smaller buildings are heated and cooled. That is the worthwhile backdrop for a HelloNation article featuring HVAC expert Natasha Adams. The source notes are lean—really lean—and do not spell out her specific guidance, product comparisons, efficiency figures,...
Continue Reading
Back-office drudgery rarely gets anyone’s pulse racing, yet it can quietly chew through a small business’s time and cash. That is why Melio’s latest recognition as Software Experts’ top pick for accounts payable automation deserves a look. The product pitch is straightforward: pull bills, approvals, payments and reconciliation into one workflow rather than leaving...
Continue Reading
A continent can be blanketed in signal and still feel digitally stranded. That is the stubborn fact sitting inside the GSMA Digital Africa Index 2026: mobile broadband reaches 92% of Africa’s population, while only 28% use mobile internet on their own devices. The 64% usage gap is not a rounding error or a tidy policy footnote. It is the whole unfinished job. From an...
Continue Reading
A thousand dollars in gift cards can look modest beside the noise of holiday marketing, but it lands differently when a family is carrying the weight of a child’s life-threatening illness. Makers Nutrition, a Hauppauge, New York-based private-label and custom supplement manufacturer, has donated $1,000 in gift cards to Friends of Karen for the nonprofit’s annual...
Continue Reading
A three-month slice of 2026 has landed Build-A-Bear in the sort of mess investors hate most: a securities complaint centered on whether management's upbeat messaging had already outrun the facts. The lawsuit targets purchases of BBW shares from May 28, 2026 through August 26, 2026, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and...
Continue Reading
Triple-negative is a heavy phrase to hand somebody without a map. Tigerlily Foundation and the Breast Cancer Resource Center are trying to close that gap with a national education campaign scheduled to launch publicly on January 11, 2027. The plan is straightforward on paper: train and mobilize 100 patient advocates across the country to explain triple-negative breast...
Continue Reading
Top 5 Most Recently Viewed Articles
374Water Secures Significant Contract for AFFF Destruction In an exciting development, 374Water Inc. (NASDAQ: SCWO) has recently secured a crucial contract to tackle the destruction of Aqueous Film-Forming Foam (AFFF) as part of North Carolina's efforts to manage hazardous materials. This initiative is pivotal in addressing the harmful effects of per- and polyfluoroalkyl...
Continue Reading
Matt Hougan, Chief Investment Officer of Bitwise Asset Management, isn't sugarcoating it—crypto’s in a bear phase. You know this drill; it's like déjà vu from past crypto winters in 2018 and 2022. Traders are feeling that chill already as the market grapples with extreme fear sentiment readings that indicate we might’ve been in this winter longer than most want to...
Continue Reading
Understanding the Gender Diversity Gap in Tech Recent findings indicate a substantial gap in gender diversity within the technology sector. A staggering 87 percent of IT professionals recognize this issue, yet only 41 percent of businesses have developed programs to actively recruit more women. This data sheds light on the challenges women face in entering and advancing...
Continue Reading
Parker Barrile Joins Dave as Chief Product Officer Los Angeles – In an exciting development for Dave Inc. (Nasdaq: DAVE), a prominent player in the neobank sector, Parker Barrile has been appointed as the Chief Product Officer. This strategic decision is set to take effect soon, marking a pivotal moment in the company’s growth story. Experience and Vision Parker...
Continue Reading
What to Expect from Northern Trust's Upcoming Earnings Northern Trust (NASDAQ:NTRS) is poised to release its latest quarterly earnings report soon. Investors are eagerly awaiting insights on the company’s financial performance and outlook. Understanding the key metrics and analyst expectations can help guide investment decisions. Current Earnings Expectations Analysts...
Continue Reading